Welcome to our dedicated page for Acadia Healthcare Company SEC filings (Ticker: ACHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Acadia Healthcare Company's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Acadia Healthcare Company's regulatory disclosures and financial reporting.
Acadia Healthcare Company, Inc. is providing preliminary 2026 guidance and an interim operating update alongside a conference appearance. For 2026, the company expects total capital expenditures to decline by at least $300 million compared with its 2025 capital expenditure guidance of $600 to $650 million, indicating a materially lower investment spend next year. Acadia also expects to add 500 to 700 beds in 2026, including beds already under construction in 2025, highlighting ongoing capacity expansion.
For the third quarter of 2025, Acadia is disclosing a select interim operating metric, reporting same facility patient days growth to date of approximately 1.3%. The company notes that forward-looking statements, including these expectations, are subject to risks such as integration of expansions and acquisitions, changes in government and commercial reimbursement, the impact of the One Big Beautiful Bill Act on Medicaid financing and eligibility, labor and cost pressures, cybersecurity risks, and broader economic conditions.
Timothy Sides, Interim CFO of Acadia Healthcare (ACHC), reports direct beneficial ownership of 30,661 shares of common stock and ownership of stock options covering 4,825 underlying shares. The options include grants exercisable in 2022, 2023, and 2024 with exercise prices of $57.14, $53.40, and $80.87 and expirations in 2031, 2032, and 2033 respectively. Several equity awards have staggered vesting schedules that begin in 2026 and extend up to three years.
Wellington Management and related entities report beneficial ownership of 8,430,343 shares of Acadia Healthcare Company, Inc. common stock, representing approximately 9.15% of the class. The filing shows no sole voting or dispositive power; instead Wellington discloses shared voting power of 7,995,273 shares and shared dispositive power of 8,430,343 shares. The ownership is held of record by clients of Wellington’s investment advisers rather than by Wellington as a principal.
The filing identifies multiple Wellington entities as reporting persons, including entities classified as holding companies (HC) and investment advisers (IA). The filing also names the Vanguard Health Care Fund as an exception noted in the list of clients, without specifying a percentage for that fund.